國家衛生研究院 NHRI:Item 3990099045/7698
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 910157      線上人數 : 809
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7698


    題名: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
    作者: Liu, SC;Tsang, NM;Chiang, WC;Chang, KP;Hsueh, C;Liang, Y;Juang, JL;Chow, KPN;Chang, YS
    貢獻者: Institute of Molecular and Genomic Medicine
    摘要: Radioresistance of EBV-associated nasopharyngeal carcinoma (NPC) is associated with poor prognosis for patients with this form of cancer. Here, we found that NPC patients had increased serum levels of leukemia inhibitory factor (LIF) and that higher LIP levels correlated with local tumor recurrence. Furthermore, in vitro studies with NPC cells and in vivo xenograft mouse studies demonstrated that LIF critically contributes to NPC tumor growth and radioresistance. Using these model systems, we found that LIP treatment activated the mTORC1/p70S6K signaling pathway, enhanced tumor growth, inhibited DNA damage responses, and enhanced radioresistance. Treatment with either soluble LIF receptor (sLIFR), a LIP antagonist, or the mTOR inhibitor rapamycin reversed LIP-mediated effects, resulting in growth arrest and increased sensitivity to gamma irradiation. Immunohistochemical (IHC) analyses of human NPC biopsies revealed that LIF and LIFR were overexpressed in tumor cells and that LIP expression correlated with the presence of the activated p-p70S6K. Finally, we found that the EBV-encoded protein latent membrane protein 1 (LMP1) enhances LIP production. Together, our findings indicate that LIP promotes NPC tumorigenesis and suggest that serum LIP levels may predict local recurrence and radiosensitivity in NPC patients.
    日期: 2013-12-02
    關聯: Journal of Clinical Investigation. 2013 Dec 2;123(12):5269-5283.
    Link to: http://dx.doi.org/10.1172/jci63428ds1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0021-9738&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000327826100031
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84890110205
    顯示於類別:[莊志立] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PB2013122402.pdf7543KbAdobe PDF703檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋